Loading...
•
Dec 31, 2024
3M Q4 2024 Earnings Report
3M reported mixed Q4 2024 results with a slight sales increase and adjusted EPS decrease, alongside full-year 2025 financial guidance.
Key Takeaways
3M reported Q4 sales of $6.0 billion, a 0.1% increase year-over-year, and adjusted sales of $5.8 billion with organic growth up 2.1%. GAAP EPS from continuing operations was $1.33, up 17% year-over-year, while adjusted EPS from continuing operations was $1.68, down 2%. The company initiated full-year 2025 financial guidance, projecting adjusted total sales growth of 0.5 to 1.5 percent and adjusted EPS in the range of $7.60 to $7.90.
Q4 sales increased slightly by 0.1% year-over-year to $6.0 billion.
GAAP EPS from continuing operations rose 17% year-over-year to $1.33.
Adjusted EPS from continuing operations decreased by 2% year-over-year to $1.68.
Full-year 2025 guidance projects adjusted EPS in the range of $7.60 to $7.90.
3M
3M
3M Revenue by Segment
Revenue by Segment
Consumer Revenue
CapyFin.com Forward Guidance
3M provided full-year 2025 expectations, including adjusted total sales growth in the range of 0.5 to 1.5 percent, reflecting adjusted organic sales growth of 2 to 3 percent, and adjusted EPS in the range of $7.60 to $7.90.
Positive Outlook
- Adjusted total sales growth in the range of 0.5 to 1.5 percent.
- Adjusted organic sales growth of 2 to 3 percent.
- Adjusted EPS in the range of $7.60 to $7.90.
- Adjusted operating cash flow of $5.2 to $5.3 billion.
- Approximately 100 percent adjusted free cash flow conversion.
Challenges Ahead
- 3M cannot forecast certain items required to develop meaningful comparable GAAP financial measures without unreasonable effort.
- Special items such as net costs for significant litigation are subject to limitations in predictability.
- Projected divestiture gains and costs are difficult to forecast.
- Changes in value of Solventum ownership are unpredictable.
- Estimates of income and associated activity of exited manufactured PFAS products are subject to limitations.